Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 35Colonic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 11Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 8Uterine Cervical Neoplasms 7Obesity 7Motor Activity 7Lung Neoplasms 7Overweight 6Depression 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Tobacco Use Disorder 4Sexuality 4Sexual Dysfunction, Physiological 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3

Interventions

olaparib 9Carboplatin 3talazoparib 1pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Paclitaxel 1Genetic Counseling 1Counseling 1ABT-767 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fanconi Anemia, Complementation Group D1 × Counseling × Clear all
NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
170 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡